Cargando…

Thioredoxin 2 Offers Protection against Mitochondrial Oxidative Stress in H9c2 Cells and against Myocardial Hypertrophy Induced by Hyperglycemia

Mitochondrial oxidative stress is thought to be a key contributor towards the development of diabetic cardiomyopathy. Thioredoxin 2 (Trx2) is a mitochondrial antioxidant that, along with Trx reductase 2 (TrxR2) and peroxiredoxin 3 (Prx3), scavenges H(2)O(2) and offers protection against oxidative st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hong, Xu, Changqing, Li, Quanfeng, Gao, Xiuxiang, Sugano, Erkio, Tomita, Hiroshi, Yang, Liming, Shi, Sa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618607/ https://www.ncbi.nlm.nih.gov/pubmed/28914755 http://dx.doi.org/10.3390/ijms18091958

Ejemplares similares

Essential Role of Thioredoxin 2 in Mitigating Oxidative Stress in Retinal Epithelial Cells
por: Sugano, Eriko, et al.
Publicado: (2013)

The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats
por: Wu, Xiaolong, et al.
Publicado: (2021)

Loss of myocardial protection against myocardial infarction in middle-aged transgenic mice overexpressing cardiac thioredoxin-1
por: D´Annunzio, Verónica, et al.
Publicado: (2016)

Protective effect of hydrogen sulphide against myocardial hypertrophy in mice
por: Shao, Mingjing, et al.
Publicado: (2017)

Investigating the Mechanism of Hyperglycemia-Induced Fetal Cardiac Hypertrophy
por: Han, Sha-sha, et al.
Publicado: (2015)

Beclin1 haploinsufficiency compromises mesenchymal stem cell-offered cardioprotection against myocardial infarction
por: Qin, Xing, et al.
Publicado: (2022)

Pyrroloquinoline quinone modulates YAP-related anti-ferroptotic activity to protect against myocardial hypertrophy
por: Zhou, Jiabin, et al.
Publicado: (2022)

Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231
por: Turturro, Francesco, et al.
Publicado: (2007)

TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells
por: Cheng, Kai-Chun, et al.
Publicado: (2019)

Immunoprotection against Cryptococcosis Offered by Znf2 Depends on Capsule and the Hyphal Morphology
por: Lin, Jianfeng, et al.
Publicado: (2022)

High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels
por: Ichinomiya, Taiga, et al.
Publicado: (2012)

The Role of Thioredoxin/Peroxiredoxin in the β-Cell Defense Against Oxidative Damage
por: Stancill, Jennifer S., et al.
Publicado: (2021)

Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis
por: Pan, Liming, et al.
Publicado: (2017)

Decoy Exosomes Offer Protection Against Chemotherapy‐Induced Toxicity
por: Fan, Miao, et al.
Publicado: (2022)

METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury
por: Wang, Lijun, et al.
Publicado: (2022)

SIRT2 inhibition protects against cardiac hypertrophy and ischemic injury
por: Yang, Xiaoyan, et al.
Publicado: (2023)

Sheng Mai San protects H9C2 cells against hyperglycemia-induced apoptosis
por: Pang, Bing, et al.
Publicado: (2019)

CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy
por: Westphal, Christina, et al.
Publicado: (2013)

Does wearing masks offer protection against viruses?
por: Donaldson, Alex
Publicado: (2020)

Can vitamin D offer protection against the coronavirus?
por: Wilson, Clare
Publicado: (2020)

Effectiveness of Albumin-Fused Thioredoxin against 6-Hydroxydopamine-Induced Neurotoxicity In Vitro
por: Sakakibara, Okina, et al.
Publicado: (2023)

2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy
por: Maayah, Zaid H., et al.
Publicado: (2018)

H(2)S Protects against Cardiac Cell Hypertrophy through Regulation of Selenoproteins
por: Greasley, Adam, et al.
Publicado: (2019)

Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy
por: Zhu, Fuyu, et al.
Publicado: (2022)

Can Monoclonal Antibodies against CGRP Offer New Treatment Options for Type 2 Diabetes?
por: Riera, Celine E
Publicado: (2020)

ACE2 overexpression in corticotropin-releasing-hormone cells offers protection against pulmonary hypertension
por: Oliveira, Aline C., et al.
Publicado: (2023)

Comparison of age‐dependent alterations in thioredoxin 2 and thioredoxin reductase 2 expressions in hippocampi between mice and rats
por: Yoo, Yeon Ho, et al.
Publicado: (2021)

Sequence analysis, expression profiles and function of thioredoxin 2 and thioredoxin reductase 1 in resistance to nucleopolyhedrovirus in Helicoverpa armigera
por: Zhang, Songdou, et al.
Publicado: (2015)

Sulforaphane-induced transcription of thioredoxin reductase in lens: possible significance against cataract formation
por: Varma, Shambhu D, et al.
Publicado: (2013)

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2010)

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2009)

Can Tofacitinib Offer Protection against COVID-19 Infection?
por: Goldberger, Tal, et al.
Publicado: (2021)

Altruism and “love of neighbor” offer neuroanatomical protection against depression
por: Miller, Lisa, et al.
Publicado: (2021)

Comparison of the structure and activity of thioredoxin 2 and thioredoxin 1 from Acinetobacter baumannii
por: Chang, Ye Ji, et al.
Publicado: (2023)

Cholecystokinin Expression in the Development of Myocardial Hypertrophy
por: Han, Zhongshu, et al.
Publicado: (2021)

Myocardial hypertrophy reduces transmural variation in mitochondrial function
por: Haynes, Premi, et al.
Publicado: (2014)

Thioredoxin-Interacting Protein in Cancer and Diabetes
por: Masutani, Hiroshi
Publicado: (2022)

H(2)S Prodrug, SG-1002, Protects against Myocardial Oxidative Damage and Hypertrophy In Vitro via Induction of Cystathionine β-Synthase and Antioxidant Proteins
por: Islam, Rahib K., et al.
Publicado: (2023)

Targeting the thioredoxin system as a novel strategy against B‐cell acute lymphoblastic leukemia
por: Fidyt, Klaudyna, et al.
Publicado: (2019)

Thioredoxin Reductase Is a Valid Target for Antimicrobial Therapeutic Development Against Gram-Positive Bacteria
por: Felix, LewisOscar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3i27faqs0bfapsec9bgabp2gn4